Adjuvatis
Research - Lyon, Auvergne-Rhône-Alpes, France
Adjuvatis Employees
Adjuvatis Details
Adjuvatis, a French start up in Biotechnology created in December 2013, develops a new eco-compatible delivery system initially designed by researchers from a joint unit between the public institution CNRS and the private company bioMerieux. Ten years of research development and evaluation at international level has allowed the creation of Adjuvatis. Adjuvatis is specialized in the development, manufacturing and formulation of around 200 nm biodegradable particles based on poly(lactic acid), called i-Particles® and produced by an eco-compatible method, surfactant free. Our company's key objective is to share the i-Particles® technology and help researchers, biopharmaceutical & diagnostic companies in: - the development of new adjuvants for safer and more efficient vaccines (animal & human vaccines) - VACCINE PLATFORM - the generation of new antibodies (polyclonal and monoclonal) using hard to use antigens formulated on our particles - ANTIBODY GENERATION - offering new drug delivery solutions by a shear-free encapsulation method - DELIVERY PLATFORMOur particles were evaluated as adjuvant especially for vaccine development (animal & human vaccines), and as drug delivery system in oncology, dermatology, infections, etc.
Adjuvatis Technologies
Load Balancers
Apache
CMS
WordPress.org
Fonts
Google Font API
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework